Rua Bioscience burns through $6.2m

Rua Bioscience burns through $6.2m
Rua: R&D spending up. (Image: Supplied)
Brent Melville
Listed medicinal cannabis firm Rua Bioscience almost doubled its cash burn rate for the year to June, recording a loss before tax of $6.17 million, from a loss of $3.59m last year.That was after research and development spending jumped to $1.9m, from $1.29m in 2020, reflecting the costs of developing the firm’s product lines, and investment into cultivation and manufacturing. The East Coast-based firm’s income came in the form of a government research and development grant of $357,366 and a covid wage subsidy of $91,636. It emp...

More Markets

NZ sharemarket dips as interest rates cut
Markets Market Close

NZ sharemarket dips as interest rates cut

The S&P/NZX 50 Index closed at 13,033.36, down 17.76 points or 0.14%.

Staff reporters 19 Feb 2025
NZME confirms job cuts
Markets

NZME confirms job cuts

About 30 roles are being cut from the NZ Herald newsroom, and several well-known journalistic names – including the political editor – have opted for voluntary redundancy.While the company has reduced the overall number of net redundancies from about 38 to 30, it still expects to...

Staff reporters 19 Feb 2025
Meridian Energy to purchase NZ Windfarms
Markets

Meridian Energy to purchase NZ Windfarms

The two companies are 50:50 partners in a plan to upgrade the Te Rere Hau windfarm.

Greg Hurrell 19 Feb 2025
Fonterra still looking at trade sale and IPO options
Primary Sector

Fonterra still looking at trade sale and IPO options

Fonterra says it is thoroughly testing both options. 

Rebecca Howard 19 Feb 2025